Literature DB >> 18585497

Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.

Stephan Rietbrock1, Emma Heeley, Jonathan Plumb, Tjeerd van Staa.   

Abstract

BACKGROUND: The aim of the study is to estimate the incidence and prevalence of chronic AF (cAF) in the United Kingdom and test the accuracy of the CHADS2 score for stroke prediction.
METHODS: The General Practice Research Database was used to identify patients aged 40+ years diagnosed with cAF and control patients. Harrell's C-statistic was used to test possible improvements in CHADS2.
RESULTS: The study population included 51,807 cAF patients. The incidence of cAF increased by age and was higher in men than women. The prevalence of cAF has increased over time. The excess 5-year risk for stroke in cAF patients correlated well with CHADS2 as follows: score 0, 1.9% (95% CI 1.6-2.1); 1, 3.0% (95% CI 2.7-3.3); 2, 4.7% (95% CI 4.3-5.1); 3, 7.2% (95% CI 6.6-7.9); 4, 10.5% (95% CI 9.4-11.5); 5, 13.9% (95% CI 12.2-15.5); and 6, 15.8% (95% CI 13.5-18.1). Adding sex, the extension of age categories and reweighing of established risk factors improved CHADS2 accuracy (C-statistic 0.68-0.72). Applying the reclassification resulted in a substantial number of patients changing stroke risk category.
CONCLUSION: Atrial fibrillation is a prevalent and growing problem, which significantly increases the risk of ischemic stroke. The CHADS2 score is a good predictor of the stroke risk but could be improved.

Entities:  

Mesh:

Year:  2008        PMID: 18585497     DOI: 10.1016/j.ahj.2008.03.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  54 in total

1.  Identifying a high stroke risk subgroup in individuals with heart failure.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia J Howard; Virginia G Wadley; Monika M Safford; James F Meschia; Aaron Anderson; George Howard; Elsayed Z Soliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-03       Impact factor: 2.136

2.  Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.

Authors:  Daniela Poli; Sophie Testa; Emilia Antonucci; Elisa Grifoni; Oriana Paoletti; Gregory Y H Lip
Journal:  Chest       Date:  2011-04-21       Impact factor: 9.410

Review 3.  Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.

Authors:  Wen-Gen Zhu; Qin-Mei Xiong; Kui Hong
Journal:  Tex Heart Inst J       Date:  2015-02-01

4.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

5.  Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.

Authors:  Demilade Adedinsewo; Junjun Xu; Pradyumna Agasthi; Adesoji Oderinde; Oluwatoyosi Adekeye; Rajesh Sachdeva; George Rust; Anekwe Onwuanyi
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-05

6.  To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.

Authors:  Simone Birocchi; Giulia Cernuschi; Gian Marco Podda; Giorgio Costantino
Journal:  Intern Emerg Med       Date:  2012-07-31       Impact factor: 3.397

Review 7.  Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation.

Authors:  Sara R Vazquez; Stacy A Johnson; Matthew T Rondina
Journal:  Thromb Res       Date:  2010-01-06       Impact factor: 3.944

8.  Incident heart failure in relation to vascular disease: insights from the Health, Aging, and Body Composition Study.

Authors:  Hassan Khan; Andreas P Kalogeropoulos; Faiez Zannad; Catherine N Marti; Peter W F Wilson; Vasiliki V Georgiopoulou; Alka M Kanaya; Anne B Newman; Erik Schelbert; Tamara B Harris; Stephen Kritchevsky; Clyde Yancy; Mihai Gheorghiade; Gregg C Fonarow; Javed Butler
Journal:  Eur J Heart Fail       Date:  2014-02-27       Impact factor: 15.534

Review 9.  Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making.

Authors:  Yishen Wang; Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2014-02

10.  Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database.

Authors:  Martin C Gulliford; Judith Charlton; Mark Ashworth; Anthony G Rudd; Andre Michael Toschke
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.